<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-molecules-26-00654">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yildiz</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Cetin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Demirci</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Polat</surname>
    <given-names>Z.A.</given-names>
   </name>
   <name>
    <surname>Kiyan</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Altun</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cetin</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Yildiz</surname>
    <given-names>O.K.</given-names>
   </name>
   <name>
    <surname>Goze</surname>
    <given-names>I.</given-names>
   </name>
  </person-group>
  <article-title>Anti angiogenic effects of diltiazem, imatinib and bevacizumab in the CAM assay</article-title>
  <source>Int. J. Sci. Res. Pub.</source>
  <year>2013</year>
  <volume>3</volume>
  <fpage>1</fpage>
  <lpage>8</lpage>
 </element-citation>
</ref>
